Profiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey

dc.authorid0000-0002-2085-2986
dc.authorid0000-0002-9316-771X
dc.authorid0000-0002-7674-6795
dc.authorid0000-0003-2543-9987
dc.authorid0000-0002-5650-6911
dc.authorid0000-0002-8208-8485
dc.authorid0000-0002-0550-4182
dc.contributor.authorEl-Sokkary, Rehab
dc.contributor.authorUysal, Serhat
dc.contributor.authorErdem, Hakan
dc.contributor.authorKullar, Ravina
dc.contributor.authorPekok, Abdullah Umut
dc.contributor.authorAmer, Fatma
dc.contributor.authorGrgic, Svjetlana
dc.date.accessioned2025-05-10T19:54:58Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractEvaluating trends in antibiotic resistance is a requisite. The study aimed to analyze the profile of multidrug-resistant organisms (MDROs) among hospitalized patients with bacteremia in intensive care units (ICUs) in a large geographical area. This is a 1-month cross-sectional survey for blood-borne pathogens in 57 ICUs from 24 countries with different income levels: lower-middle-income (LMI), upper-middle-income (UMI), and high-income (HI) countries. Multidrug-resistant (MDR), extensively drug-resistant (XDR), or pan-drug-resistant isolates were searched. Logistic regression analysis determined resistance predictors among MDROs. Community-acquired infections were comparable to hospital-acquired infections particularly in LMI (94/202; 46.5% vs 108/202; 53.5%). Although MDR (65.1%; 502/771) and XDR (4.9%; 38/771) were common, no pan-drug-resistant isolate was recovered. In total, 32.1% of MDR were Klebsiella pneumoniae, and 55.3% of XDR were Acinetobacter baumannii. The highest MDR and XDR rates were in UMI and LMI, respectively, with no XDR revealed from HI. Predictors of MDR acquisition were male gender (OR, 12.11; 95% CI, 3.025-15.585) and the hospital-acquired origin of bacteremia (OR, 2.643; 95%CI, 1.462-3.894), and XDR acquisition was due to bacteremia in UMI (OR, 3.344; 95%CI, 1.189-5.626) and admission to medical-surgical ICUs (OR, 1.481; 95% CI, 1.076-2.037). We confirm the urgent need to expand stewardship activities to community settings especially in LMI, with more paid attention to the drugs with a higher potential for resistance. Empowering microbiology laboratories and reports to direct prescribing decisions should be prioritized. Supporting stewardship in ICUs, the mixed medical-surgical ones in particular, is warranted.
dc.identifier.doi10.1007/s10096-021-04288-1
dc.identifier.endpage2334
dc.identifier.issn0934-9723
dc.identifier.issn1435-4373
dc.identifier.issue11
dc.identifier.pmid34155547
dc.identifier.scopus2-s2.0-85117479837
dc.identifier.scopusqualityQ1
dc.identifier.startpage2323
dc.identifier.urihttps://doi.org/10.1007/s10096-021-04288-1
dc.identifier.urihttps://hdl.handle.net/20.500.14730/13189
dc.identifier.volume40
dc.identifier.wosWOS:000664017300001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofEuropean Journal of Clinical Microbiology & Infectious Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectMultidrug resistance
dc.subjectInfection control
dc.subjectStewardship
dc.subjectLow- and upper-middle and high income
dc.subjectXDR
dc.subjectPan-drug resistance
dc.titleProfiles of multidrug-resistant organisms among patients with bacteremia in intensive care units: an international ID-IRI survey
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
13189
Boyut:
1.25 MB
Biçim:
Adobe Portable Document Format